Cargando…
Antihistamines as an early treatment for Covid-19
Infection with SARs-COV-2 results in COVID-19 disease. Between March 2020 and August 2021, 468 COVID-19 patients confirmed by PCR or antigen test, in Yepes, Spain, received early treatment with antihistamines, adding azithromycin in selected cases. The primary endpoint is the hospitalization rate of...
Autores principales: | Morán Blanco, Juan Ignacio, Alvarenga Bonilla, Judith A., Fremont-Smith, Philip, Villar Gómez de las Heras, Karina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129342/ https://www.ncbi.nlm.nih.gov/pubmed/37128299 http://dx.doi.org/10.1016/j.heliyon.2023.e15772 |
Ejemplares similares
-
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients
por: Morán Blanco, Juan Ignacio, et al.
Publicado: (2021) -
Identification of antiviral antihistamines for COVID-19 repurposing
por: Reznikov, Leah R., et al.
Publicado: (2021) -
Antihistamines in the treatment of pruritus in psoriasis
por: Domagała, Anna, et al.
Publicado: (2017) -
Ambivalent antihistamines.
Publicado: (1994) -
Pharmacology of Antihistamines
por: Church, Martin K, et al.
Publicado: (2013)